These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1399 related articles for article (PubMed ID: 14630541)
1. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation. Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541 [TBL] [Abstract][Full Text] [Related]
2. Role for ATM in DNA damage-induced phosphorylation of BRCA1. Gatei M; Scott SP; Filippovitch I; Soronika N; Lavin MF; Weber B; Khanna KK Cancer Res; 2000 Jun; 60(12):3299-304. PubMed ID: 10866324 [TBL] [Abstract][Full Text] [Related]
3. Role of DNA-dependent protein kinase in the process of radiation-induced aberration formation. Virsik-Köpp P; Rave-Fränk M; Hofman-Hüther H; Schmidberger H Int J Radiat Biol; 2004 Feb; 80(2):125-33. PubMed ID: 15164794 [TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation. Xu B; O'Donnell AH; Kim ST; Kastan MB Cancer Res; 2002 Aug; 62(16):4588-91. PubMed ID: 12183412 [TBL] [Abstract][Full Text] [Related]
5. BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage. Fabbro M; Savage K; Hobson K; Deans AJ; Powell SN; McArthur GA; Khanna KK J Biol Chem; 2004 Jul; 279(30):31251-8. PubMed ID: 15159397 [TBL] [Abstract][Full Text] [Related]
6. ATM activation by ionizing radiation requires BRCA1-associated BAAT1. Aglipay JA; Martin SA; Tawara H; Lee SW; Ouchi T J Biol Chem; 2006 Apr; 281(14):9710-8. PubMed ID: 16452482 [TBL] [Abstract][Full Text] [Related]
7. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Cortez D; Wang Y; Qin J; Elledge SJ Science; 1999 Nov; 286(5442):1162-6. PubMed ID: 10550055 [TBL] [Abstract][Full Text] [Related]
8. Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining. Wang HC; Chou WC; Shieh SY; Shen CY Cancer Res; 2006 Feb; 66(3):1391-400. PubMed ID: 16452194 [TBL] [Abstract][Full Text] [Related]
9. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Li S; Ting NS; Zheng L; Chen PL; Ziv Y; Shiloh Y; Lee EY; Lee WH Nature; 2000 Jul; 406(6792):210-5. PubMed ID: 10910365 [TBL] [Abstract][Full Text] [Related]
10. Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells. Brew CT; Aronchik I; Hsu JC; Sheen JH; Dickson RB; Bjeldanes LF; Firestone GL Int J Cancer; 2006 Feb; 118(4):857-68. PubMed ID: 16152627 [TBL] [Abstract][Full Text] [Related]
11. ATM complexes with HDM2 and promotes its rapid phosphorylation in a p53-independent manner in normal and tumor human cells exposed to ionizing radiation. de Toledo SM; Azzam EI; Dahlberg WK; Gooding TB; Little JB Oncogene; 2000 Dec; 19(54):6185-93. PubMed ID: 11175332 [TBL] [Abstract][Full Text] [Related]
12. Expression of DNA double-strand break repair proteins ATM and BRCA1 predicts survival in colorectal cancer. Grabsch H; Dattani M; Barker L; Maughan N; Maude K; Hansen O; Gabbert HE; Quirke P; Mueller W Clin Cancer Res; 2006 Mar; 12(5):1494-500. PubMed ID: 16533773 [TBL] [Abstract][Full Text] [Related]
13. Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies. Gatei M; Zhou BB; Hobson K; Scott S; Young D; Khanna KK J Biol Chem; 2001 May; 276(20):17276-80. PubMed ID: 11278964 [TBL] [Abstract][Full Text] [Related]
14. DNA damage-induced association of ATM with its target proteins requires a protein interaction domain in the N terminus of ATM. Fernandes N; Sun Y; Chen S; Paul P; Shaw RJ; Cantley LC; Price BD J Biol Chem; 2005 Apr; 280(15):15158-64. PubMed ID: 15713674 [TBL] [Abstract][Full Text] [Related]
15. Differing responses of Nijmegen breakage syndrome and ataxia telangiectasia cells to ionizing radiation. Little JB; Nagasawa H; Dahlberg WK; Zdzienicka MZ; Burma S; Chen DJ Radiat Res; 2002 Sep; 158(3):319-26. PubMed ID: 12175309 [TBL] [Abstract][Full Text] [Related]
16. Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining. Beckta JM; Dever SM; Gnawali N; Khalil A; Sule A; Golding SE; Rosenberg E; Narayanan A; Kehn-Hall K; Xu B; Povirk LF; Valerie K Oncotarget; 2015 Sep; 6(29):27674-87. PubMed ID: 26320175 [TBL] [Abstract][Full Text] [Related]
17. Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways. Keimling M; Volcic M; Csernok A; Wieland B; Dörk T; Wiesmüller L FASEB J; 2011 Nov; 25(11):3849-60. PubMed ID: 21778326 [TBL] [Abstract][Full Text] [Related]
18. Distinct functions of Nijmegen breakage syndrome in ataxia telangiectasia mutated-dependent responses to DNA damage. Lee JH; Xu B; Lee CH; Ahn JY; Song MS; Lee H; Canman CE; Lee JS; Kastan MB; Lim DS Mol Cancer Res; 2003 Jul; 1(9):674-81. PubMed ID: 12861053 [TBL] [Abstract][Full Text] [Related]
19. Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T-->G mutations, showing a less severe phenotype. Stewart GS; Last JI; Stankovic T; Haites N; Kidd AM; Byrd PJ; Taylor AM J Biol Chem; 2001 Aug; 276(32):30133-41. PubMed ID: 11382771 [TBL] [Abstract][Full Text] [Related]
20. The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer. Tommiska J; Bartkova J; Heinonen M; Hautala L; Kilpivaara O; Eerola H; Aittomäki K; Hofstetter B; Lukas J; von Smitten K; Blomqvist C; Ristimäki A; Heikkilä P; Bartek J; Nevanlinna H Oncogene; 2008 Apr; 27(17):2501-6. PubMed ID: 17982490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]